Skip to content
‹ Back to IndustriesHealthcare

The COVID-19 Public Health Emergency Ends This Week. Care Providers Should Keep Telehealth Flexibility Intact.

The COVID-19 public health emergency is coming to close this week, and with it, patients and physicians are preparing for a wave of adjustments. Many pandemic-introduced healthcare changes are set to end, including free COVID tests and treatments. Telehealth flexibilities, such as using applications like FaceTime for medical consultations, will cease, and providers will…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The COVID-19 public health emergency is coming to close this week, and with it, patients and physicians are preparing for a wave of adjustments. Many pandemic-introduced healthcare changes are set to end, including free COVID tests and treatments. Telehealth flexibilities, such as using applications like FaceTime for medical consultations, will cease, and providers will no longer be able to prescribe controlled substances via telemedicine without an in-person interaction.

The termination of a waiver to the Stark Law may also prevent providers from directly shipping specialty drugs to patients, a service essential for those in remote areas or with limited transportation access, despite the Community Oncology Alliance’s efforts to maintain this service post-emergency. Furthermore, healthcare providers face losing an emergency 20% pay increase for inpatient COVID-19 patients.

The end of pandemic-era waivers could prove challenging for hospitals to use telehealth across different locations. This is particularly challenging because the COVID-19 pandemic, despite its wide-reaching devastation, has also served as a catalyst for vital changes in healthcare delivery, most notably in telehealth.

Geoffrey Roche, Industry Lead of National Health Care Practice at Core Education PBC, digs deeper into the silver linings from the pandemic, and why the end of the COVID-19 public health emergency should be the start of a formalizing of telehealth service flexibility pioneered during the pandemic.

Geoffrey’s Thoughts

“It is so important to remind us that while the COVID public health emergency status is ending this week, there’s a couple of things that we still have to remember that are important at a time when we’ve been through this for so long. There were many changes that COVID-19 brought, particularly to our healthcare infrastructure that were actually positive, despite it being a pandemic. Some of those were with regard to telehealth.

And I think what’s important to understand about that is that through some actions, particularly that Congress took, as well as the administration took last year, or actually earlier this year, the Consolidated Appropriations Act of 2023 actually extended many of the telehealth flexibilities that were authorized during the COVID-19 public health emergency. And those extensions actually go through December 31st of 2024. Some of those extensions, just so individuals understand, relate to particularly federally qualified health centers, as well as rural health clinics, continuing to serve as a distant site provider for non-behavioral mental telehealth services, as well as Medicare patients will continue to receive telehealth services that were authorized in the calendar year of 2023 Medicare physician fee schedule, and there are no geographic restrictions for originating a site for non-behavioral mental telehealth services.

Additionally, some non-behavioral mental telehealth services will continue to be delivered using audio-only communication platforms, and an in-person visit within six months of initial behavioral mental health telehealth service, and annually thereafter, is not required. Finally, telehealth services can be provided by a physical therapist, occupational therapist, speech language pathologist, as well as audiologists. That is really, really important to understand.

However, there are some temporary changes through the end of the COVID-19 public health emergency that are important to understand. Telehealth can be provided as an accepted benefit, particularly under Medicare, and Medicare-covered providers may continue to use non-public facing application to communicate with patients without risking any federal penalties. What’s really important, particularly for the provider community, is to stay in touch, and particularly I would encourage them to visit telehealth.hhs.gov to further understand what and how this will continue to change with the conclusion of the public health emergency.

For patients, you will also want to ask your health insurance provider at any time, should there be a question, just check in with them. Understand it so that you’re clear, particularly if there may be any additional costs that may not be covered by your health insurance. At the end of the day, the benefit of COVID-19 pandemic, specifically to telehealth, allowing this additional flexibility with regard to the regulations, has actually been a positive. Expanding telehealth services so that we can reach harder to reach populations in some rural, suburban, and urban communities has actually been a positive.”

Article written by Daniel Litwin.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS said on November 3 it acquired LookDeep Health, a computer vision company, and introduced iQueue for Virtual Care, its first product built on what it calls ambient intelligence. Terms were not disclosed. The product bundles Virtual Observation, Virtual Nursing and Virtual Medicine, and LeanTaaS says hospitals can build on compatible cameras and in-room devices already installed or deploy supported hardware. The company cited reported results from LookDeep deployments, including fall-rate reductions of more than 70%, and said LookDeep's technology was evaluated in peer-reviewed research published in Frontiers in Imaging.

  • 01LeanTaaS acquired LookDeep Health and launched iQueue for Virtual Care, combining Virtual Observation, Virtual Nursing and Virtual Medicine; acquisition terms were not disclosed.
  • 02Hospitals can build on compatible cameras and in-room devices already in place or deploy supported hardware, according to LeanTaaS, which did not name camera vendors.
  • 03LeanTaaS reported results from LookDeep deployments including fall-rate reductions of more than 70% and twice as much nursing contact, figures that are the company's own and not tied to named health systems.

Nov 3, 2026

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Royal Philips reported 8% comparable order intake growth for the third quarter of 2026, driven by Diagnosis & Treatment, with comparable sales up 3% to EUR 4.4 billion and an adjusted EBITA margin of 13.0%, up 70 basis points. The company reiterated its 2026 outlook for 3% to 4.5% comparable sales growth. Philips Respironics reached an agreement in principle with the US Department of Justice to resolve previously disclosed investigations related to its recall, and Philips recorded a EUR 288 million provision in the quarter, with payment expected in the first quarter of 2027 subject to final documentation.

  • 01Comparable order intake grew 8%, matching a year earlier, with Diagnosis & Treatment the driver; the equipment order book stands at about 40% of revenue.
  • 02Comparable sales rose 3% to EUR 4.4 billion, adjusted EBITA margin reached 13.0%, and free cash flow was EUR 384 million; the 2026 outlook was reiterated.
  • 03Philips Respironics reached an agreement in principle with the DOJ on previously disclosed recall investigations, and Philips recorded a EUR 288 million provision; the settlement is subject to final documentation.

Nov 3, 2026

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agreed to acquire most of Vantive's hemodialysis business for $125 million in base consideration, plus up to $45 million in contingent payments, with closing expected mid-2027. The deal includes hemodialysis concentrates, machines, water treatment systems, and Vantive's Medolla, Italy manufacturing facility; the combined business could generate $400-450 million annually, depending on various factors.

  • 01Rockwell Medical acquires Vantive's hemodialysis concentrates, AK 98 machines, water treatment systems, and one-million-square-foot Medolla, Italy manufacturing campus for $125 million base price plus up to $45 million contingent on revenue and EBITDA milestones.
  • 02Combined business targeted to generate $400-450 million in annual revenue depending on operating performance, exchange rates, market conditions and integration.
  • 03Vantive's dialyzer portfolio, including Theranova dialyzer for expanded hemodialysis, remains with Vantive; the company will focus on home dialysis and critical care after divestiture.

Nov 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512